Page 304 - Come vivere più a lungo
P. 304

ses, 3:1196-1220, (1981).

           GALLIN  J.I., ELIN  R.J., HUBERT R.T., FAUCI A.S., KALINER M.A.,
             WOLFF S., Efficacy of Ascorbic Acid in Chediak-Higashi Syndrome: Stu-

             dies in Humans and Mice, in Blood, 53:226-234, (1979).

           GEORGE N., Vitamin E and Diabetic Ulceration. Summary, Shute Foundat-
             ion, London, Canada, 3:74-75, (1951).

           GERSON M., A Cancer Therapy: Results of Fifty Cases, 2  edizione Totality
                                                                                        a
             Books, Del Mar, California, (1958).

           GILDERSLEEVE D., Why Organized  Medicine  Sneezes  at the Common
             Cold, in Fact, luglio- agosto, pp. 21-23, (1967).

           GIKTER E., The Role of Ascorbic Acid in Cholesterol Metabolism, The Slo-

             vak Academy of Sciences, Bratislava, Cecoslovacchia, (1970).

           GIMTER E., Cholesterol:  Vitamin  C Controls Its Transformation into Bile
             Acids, in Science, 179:702, (1973).

           GIMTER E., Vitamin  C and Cholesterol,  in  Reevoluation of Vitamin C, a
             cura di A. Hanck e G. Ritzel, Hans Huber, Berna, pp. 53-66, (1977).


           GINTER E., The Role of Vitamin C in Cholesterol Catabolism and Athero-
             genesis,  The   Slovak   Academy   of   Sciences,   Bratislava,  Cecoslovacchia,

             (1975).

           GINTER E., Marginal Vitamin C Deficiency, Lipid Metabolism, and Athero-
             sclerosis, in Lipid Research, 16:167-220, (1978).

           GINTER E., Vitamin C in the Control of Hypercholesteremia in Man, in Vi-

             tamin C: New Clinical Applications in Immunology, Lipid Metabolism, and
             Cancer, a cura di A. Hanck e Hans Huber, Berna, pp. 137-152, (1982).

           GLAZEBROOK A.J. THOMSON S., The Administration of Vitamin C in a

             Large Institution and Its Effect  on General Health and Resistance to Infec-
             tion, in Journal of Hygiene, 42:1-19, (1942).

           GLOVER E., KOH E.T., TROUT D.L., Effect of Ascorbic Acid on Plasma
             Lipid and Lipoprotein Cholesterol in Normotensive  and Hypertensive  Sub-
             jects, in Federation Proceedings, 43:1057, (1984).


           GOLDBLATT M.W., A Depressor Substance in Seminai Fluid, in Journal
             of the Society of Chemical Industry, 52:1056-1057, (1933).


           GOETZL E.J., WASSERMAN S.I., GIGLI I., AUSTEN K.F., Enhancement
             of Random Migration and Chemotactic Response of Human Leukocytes by
             Ascorbic Acid, in Journal of Clinical Investigation, 53:813-818, (1974).

           GOMPERTz B., A Sketch of the Analysis  and Notation Applicable to the

             Value of Life Contingencies, in Philosophical Transactions of the Royal So-
   299   300   301   302   303   304   305   306   307   308   309